ArticleFrontiers in pharmacology2021

Naringenin Attenuates Non-Alcoholic Fatty Liver Disease by Enhancing Energy Expenditure and Regulating Autophagy via AMPK.

Ying Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.